BCR Repertoire Analysis for Precise IgG-RT Patient Selection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for selecting patients with hypogammaglobulinemia for immunoglobulin replacement therapy (IgG-RT) are inadequate, as they do not account for the diversity and maturity of B cell receptor repertoires, leading to uncertainty in determining which patients truly require treatment.
Innovation Solution
A method is developed to analyze the B cell receptor (BCR) repertoire of patients with low serum IgG concentrations by sequencing and characterizing IgG and IgM heavy chain transcripts, using criteria such as diversity index, germline identity, and somatic mutation frequency to determine the need for IgG-RT.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If serum IgG levels are used to determine need for immunoglobulin replacement therapy, then treatment decisions can be made based on simple laboratory values, but patients with low IgG levels may be incorrectly identified as needing treatment or may be denied treatment despite实际需要
Solution Approach 1:
The invention transitions from using a single parameter (serum IgG level) to using multiple parameters including BCR repertoire diversity index, germline identity percentage, and somatic mutation frequency. This multi-parameter approach allows for more precise patient stratification and treatment decision-making, resolving the contradiction between ease of operation and measurement precision by automating the assessment of these parameters through sequencing technology.
2Measurement precision
If BCR repertoire sequencing and analysis is performed to accurately identify patients needing IgG-RT, then patient selection precision is improved, but the complexity and cost of the diagnostic process increases
Solution Approach 1:
The diagnostic process is segmented into distinct analytical components: (1) generating BCR repertoire sequences from patient samples, (2) calculating diversity index values, (3) determining germline identity percentages, (4) assessing somatic mutation frequencies, and (5) integrating these parameters to predict treatment need. This segmentation allows for systematic implementation and validation of each component while reducing overall complexity through modular analysis.
Solution Approach 2:
The invention replaces manual clinical assessment and simple IgG level interpretation with automated bioinformatic analysis of BCR repertoire sequences. Computational algorithms calculate diversity indices, germline identities, and mutation frequencies, substituting complex manual evaluation with standardized computational methods that improve precision while maintaining operational feasibility.
3Reliability
If immunoglobulin replacement therapy is provided to all patients with low IgG levels, then infection risk is reduced for those who need treatment, but unnecessary treatment is administered to patients who do not benefit
Solution Approach 1:
The invention uses BCR repertoire characteristics as feedback to guide treatment decisions. By analyzing diversity index, germline identity, and somatic mutation patterns, the system provides feedback on the functional status of the patient's B cell compartment, enabling clinicians to distinguish between patients who will benefit from IgG-RT and those who will not, thereby optimizing treatment allocation and reducing unnecessary interventions.
Data Source
AI summary
The present disclosure provides a method of selecting a hypogammaglobulinemia patient that needs an immunoglobulin replacement therapy (IgG-RT) by analyzing the patient's B cell repertoire. The method can be used before treatment of the patient with IgG-RT. Further provided herein include a diagnostic product providing information for the patient selection and the method of diagnosis.